199 related articles for article (PubMed ID: 33682142)
1. Not all low fetal fraction cell-free DNA screening failures are at increased risk for aneuploidy.
Caldwell S; Almasri E; Schmidt L; Xu C; Dyr B; Wardrop J; Cacheris P
Prenat Diagn; 2021 Oct; 41(11):1372-1379. PubMed ID: 33682142
[TBL] [Abstract][Full Text] [Related]
2. Cell free DNA screening for fetal aneuploidy in Ireland: An observational study of outcomes following insufficient fetal fraction.
Creswell L; Doddy F; Manning C; Nazir SF; Lindow SW; Lynch C; O'Gorman N
Eur J Obstet Gynecol Reprod Biol; 2023 Nov; 290():143-149. PubMed ID: 37797414
[TBL] [Abstract][Full Text] [Related]
3. Obesity and no call results: optimal timing of cell-free DNA testing and redraw.
Hopkins MK; Koelper N; Caldwell S; Dyr B; Dugoff L
Am J Obstet Gynecol; 2021 Oct; 225(4):417.e1-417.e10. PubMed ID: 33839096
[TBL] [Abstract][Full Text] [Related]
4. Sequencing shorter cfDNA fragments improves the fetal DNA fraction in noninvasive prenatal testing.
Qiao L; Yu B; Liang Y; Zhang C; Wu X; Xue Y; Shen C; He Q; Lu J; Xiang J; Li H; Zheng Q; Wang T
Am J Obstet Gynecol; 2019 Oct; 221(4):345.e1-345.e11. PubMed ID: 31125545
[TBL] [Abstract][Full Text] [Related]
5. Combining the use of a fetal fraction-based risk algorithm and probability of an informative redraw in noninvasive prenatal testing for fetal aneuploidy.
Benn P; Martin K; McKanna T; Valenti E; Billings P; Demko Z
J Genet Couns; 2020 Oct; 29(5):800-806. PubMed ID: 31872514
[TBL] [Abstract][Full Text] [Related]
6. Maternal plasma genome-wide cell-free DNA can detect fetal aneuploidy in early and recurrent pregnancy loss and can be used to direct further workup.
Yaron Y; Pauta M; Badenas C; Soler A; Borobio V; Illanes C; Paz-Y-Miño F; Martinez-Portilla R; Borrell A
Hum Reprod; 2020 May; 35(5):1222-1229. PubMed ID: 32386059
[TBL] [Abstract][Full Text] [Related]
7. A fetal fraction enrichment method reduces false negatives and increases test success rate of fetal chromosome aneuploidy detection in early pregnancy loss.
Qiao L; Zhang B; Wu X; Zhang C; Xue Y; Tang H; Tang H; Shi J; Liang Y; Yu B; Wang T
J Transl Med; 2022 Aug; 20(1):345. PubMed ID: 35918754
[TBL] [Abstract][Full Text] [Related]
8. Noninvasive prenatal screening for patients with high body mass index: Evaluating the impact of a customized whole genome sequencing workflow on sensitivity and residual risk.
Muzzey D; Goldberg JD; Haverty C
Prenat Diagn; 2020 Feb; 40(3):333-341. PubMed ID: 31697845
[TBL] [Abstract][Full Text] [Related]
9. Most noninvasive prenatal screens failing due to inadequate fetal cell free DNA are negative for trisomy when repeated.
Lopes JL; Lopes GS; Enninga EAL; Kearney HM; Hoppman NL; Rowsey RA
Prenat Diagn; 2020 Jun; 40(7):831-837. PubMed ID: 32274800
[TBL] [Abstract][Full Text] [Related]
10. High Fetal Fraction on First Trimester Cell-Free DNA Aneuploidy Screening and Adverse Pregnancy Outcomes.
Shook LL; Clapp MA; Roberts PS; Bernstein SN; Goldfarb IT
Am J Perinatol; 2020 Jan; 37(1):8-13. PubMed ID: 31365936
[TBL] [Abstract][Full Text] [Related]
11. Benefits and limitations of noninvasive prenatal aneuploidy screening.
Abel DE; Alagh A
JAAPA; 2020 Apr; 33(4):49-53. PubMed ID: 32217908
[TBL] [Abstract][Full Text] [Related]
12. High-throughput fetal fraction amplification increases analytical performance of noninvasive prenatal screening.
Welker NC; Lee AK; Kjolby RAS; Wan HY; Theilmann MR; Jeon D; Goldberg JD; Haas KR; Muzzey D; Chu CS
Genet Med; 2021 Mar; 23(3):443-450. PubMed ID: 33190143
[TBL] [Abstract][Full Text] [Related]
13. Implementation of cell-free DNA-based non-invasive prenatal testing in a National Health Service Regional Genetics Laboratory.
Togneri FS; Kilby MD; Young E; Court S; Williams D; Griffiths MJ; Allen SK
Genet Res (Camb); 2019 Dec; 101():e11. PubMed ID: 31813398
[TBL] [Abstract][Full Text] [Related]
14. Inferring fetal fractions from read heterozygosity empowers the noninvasive prenatal screening.
Dang M; Xu H; Zhang J; Wang W; Bai L; Fang N; Liang L; Zhang J; Liu F; Wu Q; Wang S; Guan Y
Genet Med; 2020 Feb; 22(2):301-308. PubMed ID: 31467446
[TBL] [Abstract][Full Text] [Related]
15. Cell-free DNA fetal fraction in twin gestations in single-nucleotide polymorphism-based noninvasive prenatal screening.
Hedriana H; Martin K; Saltzman D; Billings P; Demko Z; Benn P
Prenat Diagn; 2020 Jan; 40(2):179-184. PubMed ID: 31711265
[TBL] [Abstract][Full Text] [Related]
16. Impact of cell-free fetal DNA on invasive prenatal diagnostic tests in a real-world public setting.
Herraiz I; Villalba A; Ajuria E; Barasoain A; Mendoza A; Pizarro N; Escribano D; Galindo A
J Perinat Med; 2019 Jul; 47(5):547-552. PubMed ID: 30849049
[TBL] [Abstract][Full Text] [Related]
17. The importance of determining the limit of detection of non-invasive prenatal testing methods.
Fiorentino F; Bono S; Pizzuti F; Mariano M; Polverari A; Duca S; Sessa M; Baldi M; Diano L; Spinella F
Prenat Diagn; 2016 Apr; 36(4):304-11. PubMed ID: 26815144
[TBL] [Abstract][Full Text] [Related]
18. A new era in aneuploidy screening: cfDNA testing in >30,000 multifetal gestations: Experience at one clinical laboratory.
Dyr B; Boomer T; Almasri EA; Wardrop JL; Rafalko J; Chibuk J; McCullough RM
PLoS One; 2019; 14(8):e0220979. PubMed ID: 31393959
[TBL] [Abstract][Full Text] [Related]
19. High positive predictive value 22q11.2 microdeletion screening by prenatal cell-free DNA testing that incorporates fetal fraction amplification.
Hammer C; Pierson S; Acevedo A; Goldberg J; Westover T; Chawla D; Mabey B; Muzzey D; Johansen Taber K
Prenat Diagn; 2024 Jul; 44(8):925-935. PubMed ID: 38622914
[TBL] [Abstract][Full Text] [Related]
20. Non-invasive cell-free fetal DNA testing for aneuploidy: multicenter study of 31 515 singleton pregnancies in southeastern China.
Xu L; Huang H; Lin N; Wang Y; He D; Zhang M; Chen M; Chen L; Lin Y
Ultrasound Obstet Gynecol; 2020 Feb; 55(2):242-247. PubMed ID: 31364782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
